Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 3
1977 5
1978 2
1979 1
1980 5
1981 9
1982 7
1983 19
1984 18
1985 15
1986 8
1987 9
1988 3
1989 8
1990 10
1991 6
1992 7
1993 3
1994 7
1995 7
1996 8
1997 10
1998 10
1999 15
2000 14
2001 10
2002 11
2003 15
2004 24
2005 17
2006 21
2007 19
2008 31
2009 31
2010 18
2011 26
2012 16
2013 15
2014 12
2015 7
2016 5
2017 6
2018 4
2019 1
2020 3
2021 1
2023 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

466 results

Results by year

Filters applied: . Clear all
Page 1
NADPH oxidases in Parkinson's disease: a systematic review.
Belarbi K, Cuvelier E, Destée A, Gressier B, Chartier-Harlin MC. Belarbi K, et al. Among authors: destee a. Mol Neurodegener. 2017 Nov 13;12(1):84. doi: 10.1186/s13024-017-0225-5. Mol Neurodegener. 2017. PMID: 29132391 Free PMC article. Review.
A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells.
Naaldijk Y, Fernández B, Fasiczka R, Fdez E, Leghay C, Croitoru I, Kwok JB, Boulesnane Y, Vizeneux A, Mutez E, Calvez C, Destée A, Taymans JM, Aragon AV, Yarza AB, Padmanabhan S, Delgado M, Alcalay RN, Chatterton Z, Dzamko N, Halliday G, Ruiz-Martínez J, Chartier-Harlin MC, Hilfiker S. Naaldijk Y, et al. Among authors: destee a. NPJ Parkinsons Dis. 2024 Jan 8;10(1):12. doi: 10.1038/s41531-023-00624-8. NPJ Parkinsons Dis. 2024. PMID: 38191886 Free PMC article.
LRP10 in α-synucleinopathies.
Tesson C, Brefel-Courbon C, Corvol JC, Lesage S, Brice A; French Parkinson's Disease Genetics Study Group. Tesson C, et al. Lancet Neurol. 2018 Dec;17(12):1034. doi: 10.1016/S1474-4422(18)30400-9. Epub 2018 Nov 13. Lancet Neurol. 2018. PMID: 30507386 Free article. No abstract available.
Targeting chelatable iron as a therapeutic modality in Parkinson's disease.
Devos D, Moreau C, Devedjian JC, Kluza J, Petrault M, Laloux C, Jonneaux A, Ryckewaert G, Garçon G, Rouaix N, Duhamel A, Jissendi P, Dujardin K, Auger F, Ravasi L, Hopes L, Grolez G, Firdaus W, Sablonnière B, Strubi-Vuillaume I, Zahr N, Destée A, Corvol JC, Pöltl D, Leist M, Rose C, Defebvre L, Marchetti P, Cabantchik ZI, Bordet R. Devos D, et al. Among authors: destee a. Antioxid Redox Signal. 2014 Jul 10;21(2):195-210. doi: 10.1089/ars.2013.5593. Epub 2014 Feb 6. Antioxid Redox Signal. 2014. PMID: 24251381 Free PMC article. Clinical Trial.
G51D α-synuclein mutation causes a novel parkinsonian-pyramidal syndrome.
Lesage S, Anheim M, Letournel F, Bousset L, Honoré A, Rozas N, Pieri L, Madiona K, Dürr A, Melki R, Verny C, Brice A; French Parkinson's Disease Genetics Study Group. Lesage S, et al. Ann Neurol. 2013 Apr;73(4):459-71. doi: 10.1002/ana.23894. Ann Neurol. 2013. PMID: 23526723
Xenopus laevis as a Model to Identify Translation Impairment.
de Broucker A, Semaille P, Cailliau K, Martoriati A, Comptdaer T, Bodart JF, Destée A, Chartier-Harlin MC. de Broucker A, et al. Among authors: destee a. J Vis Exp. 2015 Sep 27;(103):52724. doi: 10.3791/52724. J Vis Exp. 2015. PMID: 26437037 Free PMC article.
466 results